期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

风湿病治疗用生物制剂 被引量：3

The application of biological agents in the therapy of rheumatic diseases
下载PDF
导出
摘要 生物制剂因具有靶向特点,近10年来在风湿病治疗领域中得到了广泛应用。本文介绍目前已获准用于临床的各生物制剂的特点以及这些生物制剂类慢作用抗风湿药在各种风湿病治疗中的应用和不良反应。 The application of biological agents has made great progresses for their superiorities as targeted therapy in rheumatic diseases in recent ten years. This review will discuss the characteristics of kinds of biological agents which have been used in clinic. Their usages in rheumatic diseases and side effects as biological anti-rheumatic drugs are also included.
作者 孔宁 吕玲 万伟国
机构地区 复旦大学附属华山医院风湿科
出处 《上海医药》 CAS 2012年第7期14-18,共5页 Shanghai Medical & Pharmaceutical Journal
关键词 生物制剂 抗风湿药 风湿病 治疗 biological agents anti-rheumatic drugs rheumatic diseases therapy
分类号 R593.2 [医药卫生—内科学]
  • 相关文献

参考文献33

  • 1Tanaka Y, Takeuchi T, Inoue E, et al. Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year clinical and radiographic outcomes (RECONFIRM- II) [J]. Mod Rheumatol, 2008, 18(2): 146-152.
  • 2Takeuchi T, Miyasaka N, Inoue K, et al. Impact of trough serum level on radiographic and clinical response to infliximab plus methotrexate in patients with rheumatoid arthritis: results from the RISING study [J]. Mod Rheumatol,2009, 19(5): 478-487.
  • 3Wu E, Chen L, Birnbaum H,, et al. Retrospective claims data analysis of dosage adjustment patterns of TNF antagonists among patients with rheumatoid arthritis [J]. Curr Med Res Opin, 2008, 24(8): 2229-2240.
  • 4Emery P, Breedveld F, Van Der Heijde D, et al. Two-year clinical and radiographic results with combination etanercept- methotrexate therapy versus monotherapy in early rheumatoid arthritis: a two-year, double-blind, randomized study [J]. Arthritis Rheum, 2010, 62(3): 674-682.
  • 5Kameda H, Ueki Y, Saito K, et al. Etanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy: a randomized trial [J]. Mod Rheum, 2011, 20(6): 531-538.
  • 6Kameda H, Kanbe K, Sato E, et al. Etanercept (ETN) plus methotrexate (MTX) combination therapy resulted in a better outcome in joint damage and physical function than ETN monotherapy even in patients with active rheumatoid arthritis despite MTX treatment: 52-week results from the JESMR study [J]. J Rheum, 2011, 38(8): 1585-1592.
  • 7Chert YF, Jobanputra P, Barton P, et al. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness [J]. Health Technol Assess, 2006, 10(42): iii-iv, xi-xiii, 1-229.
  • 8Taylor PC, Ritchlin C, Mendelsohn A, et al. Maintenance of efficacy and safety with subcutaneous golimumab among patients with active rheumatoid arthritis who previously received intravenous golimumab [J]. J Rheumatol, 2011, 38 (12): 2572-2581.
  • 9Nobre CA, Callado MR, Lima JR, et al. Tuberculosis infection in rheumatic patients with infliximab therapy: experience with 157 patients [EB/OL]. http://www.springerlink.com/content/ k560814q7627m135/fulltext.pdf.
  • 10Singh JA, Christensen R, Wells GA, et al. A network meta- analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview [J]. CMAJ, 2009, 181(11): 787-796.

共引文献54

同被引文献19

引证文献3

二级引证文献17

上海医药
2012年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部